Cargando…
Bioactivity Studies of Hesperidin and XAV939
[Image: see text] The present work aimed to evaluate the reactivity of natural bioflavonoid hesperidin (HSP) and synthetically derived XAV939 (XAV) against human hepatocellular carcinoma (HepG2), human breast cancer (MDA-MB231) cancer cell lines, and related molecular and pathological profiles. Data...
Autores principales: | Fazary, Ahmed E., Alfaifi, Mohammad Y., Elbehairi, Serag Eldin I., Amer, Mohamed E., Nasr, Mohamed S. M., Abuamara, Tamer M. M., Badr, Doaa A., Ju, Yi-Hsu, Mohamed, Aly F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340382/ https://www.ncbi.nlm.nih.gov/pubmed/34368589 http://dx.doi.org/10.1021/acsomega.1c03080 |
Ejemplares similares
-
XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines
por: Renna, Cristiano, et al.
Publicado: (2015) -
Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells
por: Dittfeld, Claudia, et al.
Publicado: (2018) -
Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2020) -
XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway
por: Li, Chong, et al.
Publicado: (2018) -
Author Correction: Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2021)